<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00501085</url>
  </required_header>
  <id_info>
    <org_study_id>MedAff-LBAP201</org_study_id>
    <nct_id>NCT00501085</nct_id>
  </id_info>
  <brief_title>LAP-BAND AP Early Experience Trial (APEX)</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Apollo Endosurgery, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Apollo Endosurgery, Inc.</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the LAP-BAND AP System in severely obese patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary objective of this study was to collect additional information about the safety
      and effectiveness of the LAP-BAND AP System in a real-life clinical setting. Effectiveness
      was assessed through the collection of weight loss data, as well as other secondary
      effectiveness measurements. Safety was assessed by the incidence and severity of adverse
      events (AEs) related to treatment.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2007</start_date>
  <completion_date type="Actual">November 2013</completion_date>
  <primary_completion_date type="Actual">August 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Percent Excess Weight</measure>
    <time_frame>Baseline to 5 Years</time_frame>
    <description>Subjects' Percent Excess Weight Loss (%EWL) from baseline over the 5 year period post LAP-BAND implantation was measured. Excess Weight = Baseline weight - Ideal weight, where ideal weight is based on a BMI of 25 kg/m2.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Subject BMI From Baseline to 5 Years Post LAP-BAND Implantation</measure>
    <time_frame>Baseline to 5 years</time_frame>
    <description>Subjects' Body Mass Index (BMI) was recorded at each follow-up visit for the 5 years after LAP-BAND implantation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subject Reported Satiety</measure>
    <time_frame>Baseline to 5 Years</time_frame>
    <description>Subjects rated their level of hunger, satiety after meals, and desire to eat at all follow-up visits. Level of hunger was rated using a 6-point scale: 0 = not hungry at all to 5 = as hungry as I have ever felt. Satiety after meals was rated using a 6-point scale: 0 = not at all full to 5 = as full as I have ever felt. Desire to eat was rated using a 6-point scale: 0 = no desire at all to 5 = extremely strong desire.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subject Reported Quality of Life</measure>
    <time_frame>Baseline to 5 Years</time_frame>
    <description>Quality of Life was assessed using the Obesity and Weight-Loss Quality of Life Questionnaire (OWL-QOL-17). The OWL-QOL-17 is a survey of 17 questions, that rates quality of life on a scale of 0 (better) to 102 (lower).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subject Reported Sleepiness (Epworth Sleepiness Scale)</measure>
    <time_frame>Baseline to 5 years</time_frame>
    <description>The Epworth Sleepiness Scale (ESS) is a questionnaire used to determine a subject's level of daytime sleepiness. Subjects rate his or her chances of dozing off in different situations, which are combined into a total ESS score that can vary between zero (low level of daytime sleepiness) and 24 (high level of daytime sleepiness).</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">521</enrollment>
  <condition>Obesity, Morbid</condition>
  <arm_group>
    <arm_group_label>LAP-BAND</arm_group_label>
    <description>Patients who receive the LAP-BAND AP Adjustable Gastric Banding System.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>LAP-BAND AP Adjustable Gastric Banding System</intervention_name>
    <description>Reduction of food intake due to creation of smaller stomach pouch.</description>
    <arm_group_label>LAP-BAND</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Community sample
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient is scheduled to receive the LAP-BAND AP System

          -  Willingness to follow protocol requirements, including: the Informed Consent Form
             (ICF), Health Insurance Portability and Accountability Act (HIPAA) forms, follow-up
             schedule, completion of patient questionnaires.

        Exclusion Criteria:

          -  Per the LAP-BAND AP System Directions For Use (DFU)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Apollo Endosurgery</last_name>
    <role>Study Director</role>
    <affiliation>Apollo Endosurgery, Inc.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Apollo Endosurgery</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78746</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 11, 2007</study_first_submitted>
  <study_first_submitted_qc>July 12, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 13, 2007</study_first_posted>
  <results_first_submitted>January 8, 2015</results_first_submitted>
  <results_first_submitted_qc>January 15, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">January 19, 2015</results_first_posted>
  <last_update_submitted>January 15, 2015</last_update_submitted>
  <last_update_submitted_qc>January 15, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 19, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity, Morbid</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>521 Subjects were enrolled (defined as signing the informed consent). 515 Subjects started treatment and underwent LAP-BAND implantation. 6 Subjects did not have the LAP-BAND implanted after enrolling and signing the informed consent.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>LAP-BAND</title>
          <description>Patients who receive the LAP-BAND AP Adjustable Gastric Banding System.
LAP-BAND AP Adjustable Gastric Banding System: Reduction of food intake due to creation of smaller stomach pouch.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="515">Number of participants who were treated with the LAP-BAND System.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="83">Number of participants completing 5 year follow-up visit.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="432"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="195"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="34"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Subject Decision</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Revision Surgery</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Explantation Surgery</title>
              <participants_list>
                <participants group_id="P1" count="26"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Non-Compliance</title>
              <participants_list>
                <participants group_id="P1" count="24"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Study closed by sponsor</title>
              <participants_list>
                <participants group_id="P1" count="109"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Other loss to follow-up</title>
              <participants_list>
                <participants group_id="P1" count="32"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>The analysis population is defined as the number of subjects who underwent treatment with the LAP-BAND System.</population>
      <group_list>
        <group group_id="B1">
          <title>LAP-BAND</title>
          <description>Patients who receive the LAP-BAND AP Adjustable Gastric Banding System.
LAP-BAND AP Adjustable Gastric Banding System: Reduction of food intake due to creation of smaller stomach pouch.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="515"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="42.7" spread="10.89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age, Customized</title>
          <units>years</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <title>Median Age</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="42.7" lower_limit="18.5" upper_limit="70.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="422"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="93"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hispanic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Caucasian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="443"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other (Native American or unspecified)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Missing</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Baseline Weight</title>
          <units>pounds (lbs)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="273.9" spread="51.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body Mass Index (BMI) at Baseline</title>
          <units>kg/m2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="44.0" spread="6.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Baseline Excess Weight</title>
          <description>Excess weight is equal to subject weight minus ideal weight (ideal weight is based on having a BMI of 25)</description>
          <units>pounds (lbs)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="118.7" spread="42.46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change in Percent Excess Weight</title>
        <description>Subjects' Percent Excess Weight Loss (%EWL) from baseline over the 5 year period post LAP-BAND implantation was measured. Excess Weight = Baseline weight - Ideal weight, where ideal weight is based on a BMI of 25 kg/m2.</description>
        <time_frame>Baseline to 5 Years</time_frame>
        <population>The analysis population is defined as all subjects treated with the LAP-BAND System.</population>
        <group_list>
          <group group_id="O1">
            <title>LAP-BAND</title>
            <description>Patients who receive the LAP-BAND AP Adjustable Gastric Banding System.
LAP-BAND AP Adjustable Gastric Banding System: Reduction of food intake due to creation of smaller stomach pouch.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Percent Excess Weight</title>
          <description>Subjects' Percent Excess Weight Loss (%EWL) from baseline over the 5 year period post LAP-BAND implantation was measured. Excess Weight = Baseline weight - Ideal weight, where ideal weight is based on a BMI of 25 kg/m2.</description>
          <population>The analysis population is defined as all subjects treated with the LAP-BAND System.</population>
          <units>percentage of excess weight lost</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="515"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>%EWL from baseline 48 Weeks Post-Surgery (n=402)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-45.7" spread="21.26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>%EWL from baseline 24 Months Post-Surgery (n=304)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-50.8" spread="26.70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>%EWL from baseline 36 Months Post-Surgery (n=226)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-47.7" spread="30.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>%EWL from baseline 48 Months Post-Surgery (n=156)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-46.5" spread="27.23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>%EWL from baseline 60 Months Post-Surgery (n=84)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-45.9" spread="26.80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Subject BMI From Baseline to 5 Years Post LAP-BAND Implantation</title>
        <description>Subjects' Body Mass Index (BMI) was recorded at each follow-up visit for the 5 years after LAP-BAND implantation.</description>
        <time_frame>Baseline to 5 years</time_frame>
        <population>The analysis population is defined as all subjects treated with the LAP-BAND System.</population>
        <group_list>
          <group group_id="O1">
            <title>LAP-BAND</title>
            <description>Patients who receive the LAP-BAND AP Adjustable Gastric Banding System.
LAP-BAND AP Adjustable Gastric Banding System: Reduction of food intake due to creation of smaller stomach pouch.</description>
          </group>
        </group_list>
        <measure>
          <title>Subject BMI From Baseline to 5 Years Post LAP-BAND Implantation</title>
          <description>Subjects' Body Mass Index (BMI) was recorded at each follow-up visit for the 5 years after LAP-BAND implantation.</description>
          <population>The analysis population is defined as all subjects treated with the LAP-BAND System.</population>
          <units>kg/m2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="515"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>BMI at 48 Weeks Post-Surgery (n=402)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35.9" spread="6.39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>BMI at 24 Months Post-Surgery (n=304)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34.8" spread="6.49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>BMI at 36 Months Post-Surgery (n=226)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35.2" spread="6.98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>BMI at 48 Months Post-Surgery (n=156)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35.1" spread="6.20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>BMI at 60 Months Post-Surgery (n=84)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35.2" spread="6.49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Subject Reported Satiety</title>
        <description>Subjects rated their level of hunger, satiety after meals, and desire to eat at all follow-up visits. Level of hunger was rated using a 6-point scale: 0 = not hungry at all to 5 = as hungry as I have ever felt. Satiety after meals was rated using a 6-point scale: 0 = not at all full to 5 = as full as I have ever felt. Desire to eat was rated using a 6-point scale: 0 = no desire at all to 5 = extremely strong desire.</description>
        <time_frame>Baseline to 5 Years</time_frame>
        <population>The analysis population is defined as all subjects treated with the LAP-BAND System.</population>
        <group_list>
          <group group_id="O1">
            <title>LAP-BAND</title>
            <description>Patients who receive the LAP-BAND AP Adjustable Gastric Banding System.
LAP-BAND AP Adjustable Gastric Banding System: Reduction of food intake due to creation of smaller stomach pouch.</description>
          </group>
        </group_list>
        <measure>
          <title>Subject Reported Satiety</title>
          <description>Subjects rated their level of hunger, satiety after meals, and desire to eat at all follow-up visits. Level of hunger was rated using a 6-point scale: 0 = not hungry at all to 5 = as hungry as I have ever felt. Satiety after meals was rated using a 6-point scale: 0 = not at all full to 5 = as full as I have ever felt. Desire to eat was rated using a 6-point scale: 0 = no desire at all to 5 = extremely strong desire.</description>
          <population>The analysis population is defined as all subjects treated with the LAP-BAND System.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="515"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Level of Hunger at Baseline (n=487)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.1" spread="1.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Level of Hunger at Month 60 (n=81)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.3" spread="1.18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Level of Fullness at Baseline (n=488)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.5" spread="1.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Level of Fullness at Month 60 (n=81)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.3" spread="1.29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Level of Desire to Eat at Baseline (n=488)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.4" spread="1.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Level of Desire to Eat at Month 60 (n=81)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.7" spread="1.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Subject Reported Quality of Life</title>
        <description>Quality of Life was assessed using the Obesity and Weight-Loss Quality of Life Questionnaire (OWL-QOL-17). The OWL-QOL-17 is a survey of 17 questions, that rates quality of life on a scale of 0 (better) to 102 (lower).</description>
        <time_frame>Baseline to 5 Years</time_frame>
        <population>The analysis population is defined as all subjects treated with the LAP-BAND System.</population>
        <group_list>
          <group group_id="O1">
            <title>LAP-BAND</title>
            <description>Patients who receive the LAP-BAND AP Adjustable Gastric Banding System.
LAP-BAND AP Adjustable Gastric Banding System: Reduction of food intake due to creation of smaller stomach pouch.</description>
          </group>
        </group_list>
        <measure>
          <title>Subject Reported Quality of Life</title>
          <description>Quality of Life was assessed using the Obesity and Weight-Loss Quality of Life Questionnaire (OWL-QOL-17). The OWL-QOL-17 is a survey of 17 questions, that rates quality of life on a scale of 0 (better) to 102 (lower).</description>
          <population>The analysis population is defined as all subjects treated with the LAP-BAND System.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="515"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>OWL-QOL-17 Score at Baseline (n=496)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="69.8" spread="19.98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>OWL-QOL-17 Score at Month 60 (n=74)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34.5" spread="24.50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Subject Reported Sleepiness (Epworth Sleepiness Scale)</title>
        <description>The Epworth Sleepiness Scale (ESS) is a questionnaire used to determine a subject’s level of daytime sleepiness. Subjects rate his or her chances of dozing off in different situations, which are combined into a total ESS score that can vary between zero (low level of daytime sleepiness) and 24 (high level of daytime sleepiness).</description>
        <time_frame>Baseline to 5 years</time_frame>
        <population>The analysis population is defined as all subjects treated with the LAP-BAND System.</population>
        <group_list>
          <group group_id="O1">
            <title>LAP-BAND</title>
            <description>Patients who receive the LAP-BAND AP Adjustable Gastric Banding System.
LAP-BAND AP Adjustable Gastric Banding System: Reduction of food intake due to creation of smaller stomach pouch.</description>
          </group>
        </group_list>
        <measure>
          <title>Subject Reported Sleepiness (Epworth Sleepiness Scale)</title>
          <description>The Epworth Sleepiness Scale (ESS) is a questionnaire used to determine a subject’s level of daytime sleepiness. Subjects rate his or her chances of dozing off in different situations, which are combined into a total ESS score that can vary between zero (low level of daytime sleepiness) and 24 (high level of daytime sleepiness).</description>
          <population>The analysis population is defined as all subjects treated with the LAP-BAND System.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="515"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Reported Sleepiness at Baseline (n=498)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.0" spread="4.23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Reported Sleepiness at Month 60 (n=79)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.0" spread="3.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse Event information was collected from the time of LAP-BAND implantation to 5 years (end of study).</time_frame>
      <desc>Adverse Event data was collected for the analysis population, defined as all subjects treated with the LAP-BAND System (N=515)</desc>
      <group_list>
        <group group_id="E1">
          <title>LAP-BAND</title>
          <description>Patients who receive the LAP-BAND AP Adjustable Gastric Banding System.
LAP-BAND AP Adjustable Gastric Banding System: Reduction of food intake due to creation of smaller stomach pouch.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="38" subjects_at_risk="515"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" events="6" subjects_affected="5" subjects_at_risk="515"/>
              </event>
              <event>
                <sub_title>Dysphagia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="515"/>
              </event>
              <event>
                <sub_title>Gastric Erosion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="515"/>
              </event>
              <event>
                <sub_title>Gastric Leak</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="515"/>
              </event>
              <event>
                <sub_title>Gastric Perforation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="515"/>
              </event>
              <event>
                <sub_title>Gastric Prolapse</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="515"/>
              </event>
              <event>
                <sub_title>Gastrointestinal Stomal Tumor</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="515"/>
              </event>
              <event>
                <sub_title>Gastrointestinal Upset</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="515"/>
              </event>
              <event>
                <sub_title>Gastroesophageal Reflux Disease (GERD)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="515"/>
              </event>
              <event>
                <sub_title>Intra-abdominal Abscess</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="515"/>
              </event>
              <event>
                <sub_title>Nausea/Vomiting</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="515"/>
              </event>
              <event>
                <sub_title>Pancreatitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="515"/>
              </event>
              <event>
                <sub_title>Sepsis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="515"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Death</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="515"/>
              </event>
              <event>
                <sub_title>Device Malfunction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="515"/>
              </event>
              <event>
                <sub_title>Fibrous Band Obstruction</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="515"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="515"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="515"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Band erosion</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="515"/>
              </event>
              <event>
                <sub_title>Band removal</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="515"/>
              </event>
              <event>
                <sub_title>Band Slip</sub_title>
                <counts group_id="E1" events="16" subjects_affected="15" subjects_at_risk="515"/>
              </event>
              <event>
                <sub_title>LapBand Port Revision</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="515"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>1</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="158" subjects_at_risk="515"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Acid Reflux</sub_title>
                <counts group_id="E1" events="9" subjects_affected="8" subjects_at_risk="515"/>
              </event>
              <event>
                <sub_title>Dilated Gastric Pouch</sub_title>
                <counts group_id="E1" events="22" subjects_affected="12" subjects_at_risk="515"/>
              </event>
              <event>
                <sub_title>Dysphagia</sub_title>
                <counts group_id="E1" events="52" subjects_affected="37" subjects_at_risk="515"/>
              </event>
              <event>
                <sub_title>Epigastric pain</sub_title>
                <counts group_id="E1" events="5" subjects_affected="4" subjects_at_risk="515"/>
              </event>
              <event>
                <sub_title>Food Obstruction</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="515"/>
              </event>
              <event>
                <sub_title>Gastroesophageal Reflux Disease (GERD)</sub_title>
                <counts group_id="E1" events="17" subjects_affected="13" subjects_at_risk="515"/>
              </event>
              <event>
                <sub_title>Heartburn</sub_title>
                <counts group_id="E1" events="13" subjects_affected="11" subjects_at_risk="515"/>
              </event>
              <event>
                <sub_title>Increased Restriction</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="515"/>
              </event>
              <event>
                <sub_title>Unable to tolerate solids/liquids</sub_title>
                <counts group_id="E1" events="9" subjects_affected="6" subjects_at_risk="515"/>
              </event>
              <event>
                <sub_title>Vomiting/Nausea</sub_title>
                <counts group_id="E1" events="75" subjects_affected="42" subjects_at_risk="515"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Band Slip</sub_title>
                <counts group_id="E1" events="6" subjects_affected="4" subjects_at_risk="515"/>
              </event>
              <event>
                <sub_title>Band too tight</sub_title>
                <counts group_id="E1" events="19" subjects_affected="9" subjects_at_risk="515"/>
              </event>
              <event>
                <sub_title>Flipped Port</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="515"/>
              </event>
              <event>
                <sub_title>Pain at port site</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="515"/>
              </event>
              <event>
                <sub_title>Port Tube Leaking</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="515"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Port Site Infection</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="515"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Cholelithiasis</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="515"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Chest Pain</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="515"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="515"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Laura Eaton, R.N., BSN, CCRN-R</name_or_title>
      <organization>Apollo Endosurgery, Inc.</organization>
      <phone>949-468-9301</phone>
      <email>laura.eaton@apolloendo.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

